methyl-1-thiophene-2-yl-2,3,4,9-tetrahydro-1H-β-carboline-3-carboxylate | 223690-86-6

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 哈马拉生物碱
• 英文名称: methyl-1-thiophene-2-yl-2,3,4,9-tetrahydro-1H-β-carboline-3-carboxylate
• 英文别名: Methyl 1,2,3,4-tetrahydro-1-(2-thienyl)-9H-pyrido[3,4-b]indole-3-carboxylate；Methyl 1-(thiophen-2-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate；methyl 1-thiophen-2-yl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate
• CAS: 223690-86-6
• 化学式: C₁₇H₁₆N₂O₂S
• 分子量: 312.392
• InChiKey: KYUMJWNDZQTKTB-UHFFFAOYSA-N

物化性质

• 沸点：
  498.6±45.0 °C(Predicted)
• 密度：
  1.323±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  22
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  82.4
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  methyl-1-thiophene-2-yl-2,3,4,9-tetrahydro-1H-β-carboline-3-carboxylate 在 四丁基溴化铵 、 2-碘酰基苯甲酸 作用下， 以 二氯甲烷 、 乙腈 为溶剂， 以74%的产率得到methyl 1-(thiophen-2-yl)-9H-pyrido[3,4-b]indole-3-carboxylate
  参考文献：
  名称：

  通过Biginelli反应方便地合成1-芳基9 H -β-咔啉-3-甲醛并将其转化为二氢嘧啶酮衍生物

  摘要：

  在目前的工作中，报道了一种实用的1-芳基-β-咔啉-3-甲醛的合成方法，作为通用的结构单元及其在Biginelli反应中的应用。四步合成的起始原料是外消旋色氨酸甲酯。该过程涉及Pictet-Spengler环化，脱氢，酯还原和醇氧化步骤。使用Biginelli反应，将β-咔啉-3-甲醛进一步转化为在位置3上具有药理学意义的二氢嘧啶环的衍生物。

  DOI：

  10.1016/j.tet.2014.06.073
• 作为产物：
  描述：

  2-噻吩甲醛 、 甲基色氨酸 在 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 以78%的产率得到methyl-1-thiophene-2-yl-2,3,4,9-tetrahydro-1H-β-carboline-3-carboxylate
  参考文献：
  名称：

  通过Biginelli反应方便地合成1-芳基9 H -β-咔啉-3-甲醛并将其转化为二氢嘧啶酮衍生物

  摘要：

  在目前的工作中，报道了一种实用的1-芳基-β-咔啉-3-甲醛的合成方法，作为通用的结构单元及其在Biginelli反应中的应用。四步合成的起始原料是外消旋色氨酸甲酯。该过程涉及Pictet-Spengler环化，脱氢，酯还原和醇氧化步骤。使用Biginelli反应，将β-咔啉-3-甲醛进一步转化为在位置3上具有药理学意义的二氢嘧啶环的衍生物。

  DOI：

  10.1016/j.tet.2014.06.073

文献信息

• Reusable, homogeneous water soluble photoredox catalyzed oxidative dehydrogenation of N-heterocycles in a biphasic system: application to the synthesis of biologically active natural products
  作者：S. Srinath、R. Abinaya、Arun Prasanth、M. Mariappan、R. Sridhar、B. Baskar

  DOI：10.1039/d0gc00569j

  日期：——

  the substrate and catalyst at room temperature. Its potential applications to organic transformations are demonstrated by the synthesis of various biologically active N-heterocycles such as indoles, (iso)quinolines and β-carbolines and natural products such as eudistomin U, norharmane, and harmane and precursors to perlolyrine and flazin. Without isolation and purification, the catalyst solution can

  本文中，描述了一种在双相介质中使用可重复使用的均相钴-酞菁光氧化还原催化剂对四氢-β-咔啉，二氢吲哚和四氢-（异）喹啉进行氧化脱氢（ODH）的简单有效的方法。双相系统具有易于分离产物和均相光氧化还原催化剂有效重复使用的优点。而且，当前系统显着帮助克服了室温下底物和催化剂的溶解性问题。通过合成各种具有生物活性的N-杂环（如吲哚，（异）喹啉和β-咔啉）以及天然产物（如eudistomin U，降伤害药烷和harmane）以及全氟去氧灵和flazin的前体，证明了其在有机转化中的潜在应用。没有分离和纯化，催化剂溶液最多可重复使用5次，反应活性几乎相当。此外，以克为单位证明了反应的效率。据我们所知，这是有关在环境友好的条件下使用非贵重，可重复使用和均相的钴光氧化还原催化剂进行ODH反应的第一份报告。
• Tetracyclic derivatives, process of preparation and use
  申请人：ICOS Corporation

  公开号：US20020119976A1

  公开（公告）日：2002-08-29

  A compound of formula (I) 1 and salts and solvates thereof, in which: R o represents hydrogen, halogen or C 1-6 alkyl; R 1 represents hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, halo C 1-6 alkyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl C 1-3 alkyl, arylC 1-3 alkyl or heteroaryl C 1-3 alkyl; R 2 represents an optionally substituted monocyclic aromatic ring selected from benzene, thiophene, furan and pyridine or an optionally substituted bicyclic ring 2 attached to the rest of the molecule via one of the benzene ring carbon atoms and wherein the fused ring A is a 5- or 6-membered ring which may be saturated or partially or fully unsaturated and comprises carbon atoms and optionally one or two heteroatoms selected from oxygen, sulphur and nitrogen; and R 3 represents hydrogen or C 1-3 alkyl, or R 1 and R 3 together represent a 3- or 4-membered alkyl or alkenyl chain. A compound of formula (I) is a potent and'selective inhibitor of cyclic guanosine 3′, 5′-monophosphate specific phosphodiesterase (CGMP specific PDE) having a utility in a variety of therapeutic areas where such inhibition is beneficial, including the treatment of cardiovascular disorders.

  式(I)1的化合物及其盐和溶剂化物，其中：R代表氢，卤素或C1-6烷基；R1代表氢，C1-6烷基，C2-6烯基，C2-6炔基，卤代C1-6烷基，C3-8环烷基，C3-8环烷基C1-3烷基，芳基C1-3烷基或杂环芳基C1-3烷基；R2代表一个可选的取代的单环芳香环，选择自苯，噻吩，呋喃和吡啶或一个可选的取代的二环2，通过苯环碳原子之一连接到分子的其余部分，其中融合的环A是一个5-或6-成员环，可以是饱和的或部分或完全不饱和的，并包括碳原子和可选的一个或两个异原子，选择自氧，硫和氮；R3代表氢或C1-3烷基，或R1和R3一起代表一个3-或4-成员烷基或烯基链。式(I)的化合物是环鸟苷3'，5'-单磷酸特异性磷酸二酯酶（CGMP特异性PDE）的有效和选择性抑制剂，具有在多种治疗领域中抑制有益的功效，包括心血管疾病的治疗。
• (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione for the treatment of benign prostatic hypertrophy
  申请人：ICOS Corporation

  公开号：EP2036560A1

  公开（公告）日：2009-03-18

  Compound (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino [2', 1':6,1]pyrido[3,4-b]indcle-1,4-dione for the treatment of benign prostatic hypertrophy.

  用于治疗良性前列腺肥大的化合物 (6R,12aR)-2,3,6,7,12,12a-六氢-2-甲基-6-(3,4-亚甲基二氧苯基)-吡嗪并[2', 1':6,1]pyrido[3,4-b]indcle-1,4- 二酮。
• Tetracyclic cyclic gmp-specific phosphodiesterase inhibitors for the treatment of benign prostatic hypertrophy
  申请人：ICOS Corporation

  公开号：EP2327408A1

  公开（公告）日：2011-06-01

  A compound of formula (1) and salts and solvates thereof, in which: R0 represents hydrogen, halogen, or Cl-6alkyl; R1 represents hydrogen, C1-6-alkyl, C2-6alkenyl, C2-6alkynyl, haloC1-6alkyl, C3-8cycloalkyl, C3-8cyloalkylcl-3alkyl, arylC1-3alkyl, or heteroarylcl-3alkyl; R2 represents an optionally substituted monocyclic aromatic ring selected from benzene, thiophene, furan, and pyridine, or an optionally substituted bicyclic ring (a) attached to the rest of the molecule via one of the benzene ring carbon atoms, and wherein the fused ring (A) is a 5- or 6-membered ring which may be saturated or partially or fully unsaturated, and comprises carbon atoms and optionally one or two heteroatoms selected from oxygen, sulphur, and nitrogen; and R3 represents hydrogen or Cl-alkyl, or R1 and R3 together represent a 3- or 4-membered alkyl or alkenyl chain. A compound of formula (I) is a potent and selective inhibitor of cyclic guanosine 3', 5'-monophosphate specific phosphodiesterase (cGMP specific PDE) having a utility in a variety of therapeutic areas where such inhibition is beneficial, including the treatment of benign prostatic hypertrophy.

  式(1)化合物及其盐和溶剂，其中：R0 代表氢、卤素或 Cl-6 烷基；R1 代表氢、C1-6-烷基、C2-6-烯基、C2-6-炔基、卤代 C1-6 烷基、C3-8-环烷基、C3-8-环烷基环 3 烷基、芳基 C1-3 烷基或杂芳基环 3 烷基；R2 代表任选取代的单环芳香环，选自苯、噻吩、呋喃和吡啶，或任选取代的双环 (a)，通过其中一个苯环碳原子连接到分子的其余部分，其中融合环 (A) 是 5 或 6 元环，可以是饱和环或部分或完全不饱和环，包括碳原子和任选选自氧、硫和氮的一个或两个杂原子；R3 代表氢或 Cl-烷基，或 R1 和 R3 共同代表 3 或 4 元烷基或烯基链。式（I）化合物是环鸟苷-3'，5'-单磷酸特异性磷酸二酯酶（cGMP 特异性 PDE）的强效选择性抑制剂，可用于多种治疗领域，包括治疗良性前列腺肥大。
• Potent 1,3-Disubstituted-9<i>H</i>-pyrido[3,4-<i>b</i>]indoles as New Lead Compounds in Antifilarial Chemotherapy^,
  作者：Sanjay K. Srivastava、Alka Agarwal、Prem M. S. Chauhan、Shiv K. Agarwal、Amiya P. Bhaduri、Som N. Singh、Nigar Fatima、Ranjit K. Chatterjee

  DOI：10.1021/jm9800705

  日期：1999.5.1

  Substituted 9H-pyrido[3,4-b]indoles (beta-carbolines), identified in our laboratory as potential pharmacophores for designing macrofilaricidal agents, have been explored further for identifying the pharmacophore responsible for the high order of adulticidal activity. This has led to syntheses and macrofilaricidal evaluations of a number of 1-aryl-9H-pyrido[3,4-b]indole-3-carboxylate derivatives (3-7). The macrofilaricidal activity was initially evaluated in vivo against Acanthoeilonema viteae. Among all the synthesized compounds, only 12 compounds, namely 3a, 3c, 3d, 3f, 4c, 4d, 4f, 5a, 6f, 6h, 6i, and 7h, have exhibited either > 90% micro- or macrofilaricidal activity or sterlization of female worms. These compounds have also been screened against Litomosoides carinii, and of these only 3f and 5a have also been found to be active. Finally these two compounds have been evaluated against Brugia malayi. The structure-activity relationship (SAR) associated with position 1 and 3 substituents in beta-carbolines has been discussed. It has been observed that the presence of a carbomethoxy at position 3 and an aryl substituent at position 1 in beta-carbolines effectively enhances antifilarial activity particularly against A. viteae. Among the various compounds screened, methyl 1-(4-methylphenyl)-9H-pyrido[3,4-b] indole-3-carboxylate (4c) has shown the highest adulticidal activity and methyl 1-(4-chlorophenyl)-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole-3-carboxylate (3a) has shown the highest microfilaricidal action against A. viteae at 50 mg/kg x 5 days (ip). Another derivative of this compound, namely 1-(4-chlorophenyl)-3-(hydroxymethyl)-9H-pyrido[3,4-b]indole (5a), exhibited the highest activity against L. carinii at 30 mg/kg x 5 days tip! and against B. malayi at 50 mg/kg x 5 days tip) or at 200 mg/kg x 5 days (po).